Latest filing published 12 May 2015 for Amicus Therapeutics, INC..
Insider track record
No signal scores available.
John Kirk: trading record in brief
John Kirk appears in our data through filings on Amicus Therapeutics, Inc. shares, published by SEC (Form 4). Over a trading history stretching from 10 April 2014 to 11 May 2015, the count stands at 6 filings.
Sales make up the whole of the open-market record (2 sales, €206k). Besides market trades, the filings include 2 share grants and 2 option exercises. In 2015 alone, the filings show no purchases and 2 sales.
The newest entry dates from 12 May 2015: a share grant of €89k, in Amicus Therapeutics, Inc. The median gap between a trade and its publication by SEC (Form 4) is 4 days. For comparison, the SEC allows two business days to file a Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to John Kirk
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 25,000 sharesCommon stockSEC:0001209191-15-042023:0
- 10,110 shares@ US$11.51Common stockSEC:0001209191-15-029053:0
- 50,000 shares0Common stockSEC:0001209191-14-027190:0
3 of 3 declarations
